Cargando…

A new tool for early diagnosis of rheumatoid arthritis using combined biomarkers; synovial MAGE-1 mRNA and serum anti-CCP and RF

INTRODUCTION: rheumatoid arthritis (RA) is a common autoimmune disease with unknown etiology and pathogenesis. Biomarkers have the potential to aid in the clinical diagnosis of the disease, or to provide means of detecting early signs of the disease. Evaluating Melanoma associated antigen genes (MAG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aiman, Al-Qtaitat, Nesrin, Mwafi, Amal, Albtoosh, Nassar, Al-Dalaien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The African Field Epidemiology Network 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545977/ https://www.ncbi.nlm.nih.gov/pubmed/33088399 http://dx.doi.org/10.11604/pamj.2020.36.270.21827

Ejemplares similares

The association of anti-CCP antibodies with disease activity in rheumatoid arthritis
por: Serdaroğlu, Münevver, et al.
Publicado: (2008)

Collagen Autoantibodies and Their Relationship to CCP Antibodies and Rheumatoid Factor in the Progression of Early Rheumatoid Arthritis
por: Whittingham, Senga F., et al.
Publicado: (2017)

Adjusting for sex and anti-CCP levels in linkage analysis of rheumatoid arthritis
por: Lebrec, Jérémie JP, et al.
Publicado: (2007)

The Clinical Application of Anti-CCP in Rheumatoid Arthritis and Other Rheumatic Diseases
por: Chou, CT, et al.
Publicado: (2007)

Relation Between Anti-CCP Antibodies and Sharp Score in Rheumatoid Arthritis
por: Mekic, Mevludin, et al.
Publicado: (2020)

Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays
por: Poulsen, Thomas B. G., et al.
Publicado: (2021)

Comparative Effectiveness of Abatacept vs. Tofacitinib in Rheumatoid Arthritis Patients who are CCP+
por: Harrold, Leslie R., et al.
Publicado: (2023)

Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab
por: Fabris, Martina, et al.
Publicado: (2010)

Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers
por: Damgaard, Dres, et al.
Publicado: (2016)

Number of individual ACPA reactivities in synovial fluid immune complexes, but not serum anti-CCP2 levels, associate with inflammation and joint destruction in rheumatoid arthritis
por: Sohrabian, Azita, et al.
Publicado: (2018)

Effects of Human Leukocyte Antigen DRB1 Genetic Polymorphism on Anti-Cyclic Citrullinated Peptide (ANTI-CCP) and Rheumatoid Factor (RF) Expression in Rheumatoid Arthritis (RA) Patients
por: Chen, Yu-Chia, et al.
Publicado: (2023)

Anti-citrullinated protein antibodies in the diagnosis of rheumatoid arthritis (RA): diagnostic performance of automated anti-CCP-2 and anti-CCP-3 antibodies assays
por: Vos, Ine, et al.
Publicado: (2017)

Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis
por: Saraux, A, et al.
Publicado: (2003)

Relationship between Anti-CCP Antibodies and Oxidant and Anti-Oxidant Activity in Patients with Rheumatoid Arthritis
por: Ediz, Levent, et al.
Publicado: (2011)

Correlation between high-frequency ultrasonography of patients with early rheumatoid arthritis and anti-CCP antibody
por: Yang, Jie, et al.
Publicado: (2019)

Effect of infliximab on mRNA expression profiles in synovial tissue of rheumatoid arthritis patients
por: Lindberg, Johan, et al.
Publicado: (2006)

Synovial Histopathology in Early Rheumatoid Arthritis
por: Hirohata, Shunsei, et al.
Publicado: (2000)

Activation of Synovial Fibroblasts in Rheumatoid Arthritis
por: Gay, Steffen, et al.
Publicado: (2000)

Synovial fluid proteome in rheumatoid arthritis
por: Bhattacharjee, Mitali, et al.
Publicado: (2016)

Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes
por: Al-Jefout, Moamar, et al.
Publicado: (2017)

Anti-CCP2 Antibodies: An Overview and Perspective of the Diagnostic Abilities of this Serological Marker for Early Rheumatoid Arthritis
por: van Venrooij, Walther J., et al.
Publicado: (2007)

The association of anti-CCP1 antibodies with disease activity score 28 (DAS-28) in rheumatoid arthritis
por: Karimifar, Mansoor, et al.
Publicado: (2012)

Osteoprotegerin CGA Haplotype Protection against Cerebrovascular Complications in Anti-CCP Negative Patients with Rheumatoid Arthritis
por: Genre, Fernanda, et al.
Publicado: (2014)

The TNFA -857C/T Polymorphism: Association with Rheumatoid Arthritis and Anti-CCP Levels in a Mexican Population
por: Agraz-Cibrián, Juan Manuel, et al.
Publicado: (2019)

Differential regulation and correlation between galectin-9 and anti-CCP antibody (ACPA) in rheumatoid arthritis patients
por: Fujita, Yuya, et al.
Publicado: (2020)

Cells of the synovium in rheumatoid arthritis. Synovial fibroblasts
por: Müller-Ladner, Ulf, et al.
Publicado: (2007)

Comparison of the nodule and synovial lesions of rheumatoid arthritis
por: Highton, J, et al.
Publicado: (2003)

Evidence for synovial fibroblasts spreading rheumatoid arthritis
por: Müller-Ladner, Ulf, et al.
Publicado: (2012)

Synovial Tissue Response to Treatment in Rheumatoid Arthritis
por: Vieira-Sousa, Elsa, et al.
Publicado: (2011)

Multiomics landscape of synovial fibroblasts in rheumatoid arthritis
por: Tsuchiya, Haruka, et al.
Publicado: (2021)

Drivers of heterogeneity in synovial fibroblasts in rheumatoid arthritis
por: Smith, Melanie H., et al.
Publicado: (2023)

Antibodies to mutated citrullinated vimentin for diagnosing rheumatoid arthritis in anti-CCP-negative patients and for monitoring infliximab therapy
por: Nicaise Roland, Pascale, et al.
Publicado: (2008)

Frequency of Th17 CD4+ T Cells in Early Rheumatoid Arthritis: A Marker of Anti-CCP Seropositivity
por: Arroyo-Villa, Irene, et al.
Publicado: (2012)

P25 TB or not TB? An unusual case of inflammatory arthritis in an anti-CCP positive patient
por: Al-Attar, Mariam, et al.
Publicado: (2023)

Rheumatoid factor and anti-CCP do not predict progressive joint damage in patients with early rheumatoid arthritis treated with prednisolone: a randomised study
por: Hafström, Ingiäld, et al.
Publicado: (2014)

Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCP) affects severity of rheumatoid arthritis
por: van Gaalen, FA, et al.
Publicado: (2004)

The reporting quality of studies investigating the diagnostic accuracy of anti-CCP antibody in rheumatoid arthritis and its impact on diagnostic estimates
por: Zintzaras, Elias, et al.
Publicado: (2012)

A Closer Look at the Role of Anti-CCP Antibodies in the Pathogenesis of Rheumatoid Arthritis-Associated Interstitial Lung Disease and Bronchiectasis
por: Khan, Tanjila, et al.
Publicado: (2021)

Rheumatoid Arthritis Co-relation with Anti-CCP Antibodies with special reference to its Prevalence in Asymptomatic First-Degree Relatives
por: GR, Pramod, et al.
Publicado: (2022)

Low levels of anti-cyclic citrullinated peptide (CCP) 3.1 associated with diseases other than rheumatoid arthritis
por: Son, James J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6kcjj56cbp182c6h9hod9slgtj